SeerPharma Pty Ltd :: DISCover web-based training

Dyslipidemia: Treatment

Description: Dyslipidemia is a disorder of the amount of lipids in the blood, and is a primary risk factor for the development of atherosclerosis and subsequent cardiovascular diseases. Therefore, understanding and treating dyslipidemia is a key step in preventing life-threatening events such as stroke and myocardial infarction. This course introduces the various therapies used to treat dyslipidemia and to prevent atherosclerosis.

COURSE OUTLINE

INTRODUCTION
1. Course Information
2. Interface Tour
3. Course Overview

PROGNOSIS
4. Objectives
5. Initiation of Plaque Formation
6. Plaque Development
7. Ischemia, Stenosis and Aneurysm
8. Sites of Atherosclerosis
9. Progress Check

TREATMENT
10. Objectives
11. Non-pharmacologic Therapy
12. Bile Acid Sequestrants
13. Fibrates and Nicotinic Acid
14. The Statins: Direct Mechanisms
15. The Statins: Indirect Mechanisms
16. Progress Check

CONCLUSION
17. Summary

COURSE OBJECTIVES

Students completing this course should be able to:

Describe the characteristics of atherosclerosis
Outline the stages of atherosclerotic development
Explain the risks that may result from plaque formation within arteries
Describe the main clinical manifestations of atherosclerosis: coronary heart disease, cerebrovascular disease, and peripheral arterial disease
Discuss the non-pharmacologic therapies for dyslipidemia
Describe the different classes of lipid-lowering drugs, including their mechanisms of action, indications for use, efficacy, and adverse effects

Home

Training Programs

Upcoming Training

Compliance Consulting

DISCover e-Learning

Modules available

SOPtrain

Quality Management Software

Clinical Trials Software

SeerPharma has partnered with GeneEd to now distribute courses in Major Therapeutic Areas, Clinical Research, and Biotechnology & Genetics.